Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POLYMYXIN B vs PONATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POLYMYXIN B vs PONATINIB: Safety Overview

Metric POLYMYXIN B PONATINIB
Total FAERS Reports 644 10,011
Deaths Reported 114 2,924
Death Rate 17.7% 29.2%
Hospitalizations 200 4,254
Average Patient Age 52.8 yrs 55.8 yrs
% Female Patients 55.3% 46.2%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 23, 2015
Manufacturer Somerset Therapeutics, LLC Takeda Pharmaceuticals America, Inc.
Route OPHTHALMIC ORAL
Marketing Status Discontinued Prescription